投稿ビュー
Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications - GlobeNewswire
Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications GlobeNewswire
Sustainable Squalene Replacement Needed for Pharma. EMERYVILLE, Calif. and SEATTLE, Feb. 12, 2019 (GLOBE NEWSWIRE) -- Amyris, Inc.
評価
おすすめ
タグ
転職
"
"@type":
"@type":"NewsArticle"
"Auga Group"
"C" grade Nevada infrastructure
"Errol Oh"
"Jane Goodyear"
"Optimistically Cautious"
"a man and his prostate"
"akcijų pardavimas"
"analytics:simplereach:id":"54
"author":"Art Berman"
"author":"Brad McMillan"
"author":"Bryan Rich"
"author":"Christopher Helman"
"author":"Claire Poole"
"author":"Clare O'Connor"
"author":"David Blackmon"